Kyprolis (carfilzomib)

pCPA File Number: 20948

Negotiation Status:

Concluded with an LOI

Indication(s):

Multiple Myeloma

Sponsor/Manufacturer:

Amgen Canada Inc.

CDA-AMC Project Number:

PC0067-000

pCPA Engagement Letter Issued:

2016-10-14

Negotiation Process Concluded:

2017-12-08